首页> 外文期刊>Brazilian Journal of Medical and Biological Research >Simultaneous detection of the C282Y, H63D and S65C mutations in the hemochromatosis gene using quenched-FRET real-time PCR
【24h】

Simultaneous detection of the C282Y, H63D and S65C mutations in the hemochromatosis gene using quenched-FRET real-time PCR

机译:使用淬灭FRET实时PCR同时检测血色素沉着病基因中的C282Y,H63D和S65C突变

获取原文
           

摘要

Hereditary hemochromatosis (HH) is a common autosomal disorder of iron metabolism mainly affecting Caucasian populations. Three recurrent disease-associated mutations have been detected in the hemochromatosis gene (HFE): C282Y, H63D, and S65C. Although HH phenotype has been associated with all three mutations, C282Y is considered the most relevant mutation responsible for hemochromatosis. Clinical complications of HH include cirrhosis of the liver, congestive cardiac failure and cardiac arrhythmias, endocrine pancreatic disease, which can be prevented by early diagnosis and treatment. Therefore, a reliable genotyping method is required for presymptomatic diagnosis. We describe the simultaneous detection of the C282Y, H63D and S65C mutations in the hemochromatosis gene by real-time PCR followed by melting curve analysis using fluorescence resonance energy transfer (FRET) probes. The acceptor fluorophore may be replaced by a quencher, increasing multiplex possibilities. Real-time PCR results were compared to the results of sequencing and conventional PCR followed by restriction digestion and detection by agarose gel electrophoresis (PCR-RFLP). Genotypes from 80 individuals obtained both by the conventional PCR-RFLP method and quenched-FRET real-time PCR were in full agreement. Sequencing also confirmed the results obtained by the new method, which proved to be an accurate, rapid and cost-effective diagnostic assay. Our findings demonstrate the usefulness of real-time PCR for the simultaneous detection of mutations in the HFE gene, which allows a reduction of a significant amount of time in sample processing compared to the PCR-RFLP method, eliminates the use of toxic reagents, reduces the risk of contamination in the laboratory, and enables full process automation.
机译:遗传性血色素沉着病(HH)是铁代谢的常见常染色体疾病,主要影响白种人。已在血色素沉着病基因(HFE)中检测到三个与疾病相关的复发突变:C282Y,H63D和S65C。尽管HH表型已与所有这三个突变相关,但C282Y被认为是引起血色素沉着病的最相关突变。 HH的临床并发症包括肝硬化,充血性心力衰竭和心律不齐,内分泌胰腺疾病,可以通过早期诊断和治疗来预防。因此,症状前诊断需要可靠的基因分型方法。我们描述了实时荧光定量PCR同时检测血色素沉着病基因中C282Y,H63D和S65C突变,然后使用荧光共振能量转移(FRET)探针进行熔解曲线分析。受体荧光团可以用淬灭剂代替,从而增加了多重可能性。将实时PCR结果与测序和常规PCR结果进行比较,然后进行限制性酶切和琼脂糖凝胶电泳(PCR-RFLP)检测。通过常规PCR-RFLP方法和淬灭-FRET实时PCR获得的80个个体的基因型完全一致。测序也证实了通过新方法获得的结果,该结果被证明是一种准确,快速且具有成本效益的诊断分析方法。我们的研究结果证明了实时PCR对同时检测HFE基因突变的有用性,与PCR-RFLP方法相比,它可以减少样品处理中的大量时间,消除了有毒试剂的使用,减少了降低实验室污染的风险,并实现全过程自动化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号